6117 Circulating endothelial cells (CECs) and FDG-PET for early prediction of response in high-risk locally advanced rectal cancer (HR-LARC) patients (pts) treated with two different schedules of bevacizumab (BEV) in combination with preoperative chemo-radiotherapy (CT-RT)

✍ Scribed by Avallone, A.; Delrio, P.; Gennaro, E. Di; Pecori, B.; Caracò, C.; Tatangelo, F.; Sandomenico, C.; Petrillo, A.; Budillon, A.; Comella, P.

• Book ID: 122963410
• Publisher: Elsevier Science
• Year: 2009
• Tongue: English
• Weight: 49 KB
• Volume: 7
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/S1359-6349(09)71212-1